Sponsor Pipeline

Dong Wen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07047001 Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients… Renal Cell Carcinoma (RCC) Active, Not Recruiting
Disease Areas
Kidney Cancer (1)
Get alerts when Dong Wen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free